non glp-1 medications use tripled among non-diabetics, reaching $5.8B in 2022 Users have emphasized realistic expectations Indications for GLP-1/GIP RA Summary

How Retatrutide Compares Understanding where retatrutide fits relative to existing options helps clarify who benefits most

Use of diazoxide in management of severe postprandial hypoglycemia in patient after Roux-en-Y gastric bypass

The reality of the Ozempic Rebound underscores the importance of addressing the underlying causes that lead to weight gain to begin with

In November 2025 Novo Nordisk filed for submission to the FDA for a higher dose of semaglutide, 7.2mg

The American Diabetes Association (ADA) guidelines updated in 2023 recommend GLP-1 receptor agonists as a preferred treatment option for many patients with type 2 diabetes, particularly those with or at high risk for cardiovascular disease or kidney disease

Multiple freeze-thaw cycles, which can happen inadvertently in a poorly calibrated refrigerator, will progressively destroy the remaining active peptide until the preparation is essentially inert